Type 1 diabetes is caused when the body’s immune system attacks and destroys the cells in the pancreas that make insulin, a hormone that helps carry glucose (sugar) into cells to be used for energy.

This technology replaces syringes and vials, or prefilled insulin pen needles. These wearable devices are filled with enough insulin to last 2 to 4 days, and through a small cannula inserted just ...

In this study, significantly more patients in the insulin ... needle-stick injury, even when no infection occurs. [27] There were some limitations to this study. Some patients in the insulin pen ...

Novo launched the NovoPen - the first insulin pen device in 1985. Lars Rebien Sorensen becomes CEO after serving as the head of Novo's healthcare business. The company's enzymes business was spun ...

This issue is preventing our website from loading properly. Please review the following troubleshooting tips or contact us at [email protected]. By submitting your ...